Manufacturing, Biologics

Increased Containment Requirements and Continually Advancing Analytics are Key to Improving ADC Manufacture (INTERPHEX 2024)

April 17, 2024

ADC manufacturing facilities are requiring more stringent containment requirements as well as advanced analytical detection.

Cytiva Showcases Single-Use Mixing System at INTERPHEX 2024

April 17, 2024

The Xcellerex magnetic mixer, single-use mixing system was designed to address challenges in large-scale mAb, vaccine, and genomic medicine manufacturing processes.

Watson-Marlow Fluid Technology Solutions Launches New Single-Use Solutions for Fluid Management

April 15, 2024

WMFTS’ new WMArchitect single-use solutions offers standard ready-to-use single-use assemblies as well as customized designs for biopharma fluid management.

Evaluating Uses for Both Single-Use and Stainless-Steel Bioreactors

April 02, 2024

Despite a growing trend toward single-use bioreactors, stainless-steel retains its relevance for certain products.

Lonza Acquires Roche’s US Commercial Biologics Manufacturing Site for $1.2 Billion

March 25, 2024

With the Vacaville, Calif., site acquisition, Lonza gains one of the largest biologics manufacturing sites for mammalian cell-based therapeutics.

Review of SUT Adoption in Biopharma Manufacturing

March 15, 2024

The evolution of therapeutic modalities drives the adoption of single-use technologies.

ProBioGen and Mapp Biopharmaceutical Partner to Develop Antibody Against Marburg Virus Disease

March 15, 2024

ProBioGen and Mapp Biopharmaceutical will use the former’s GlymaxX technology to develop a cell line for an afucosylated antibody that targets Marburg virus infection

Domain Therapeutics and Chime Biologics Form Manufacturing Pact for Antibody Cancer Immunotherapy

March 13, 2024

Under a new agreement, Chime Biologics will manufacture Domain Therapeutics’ antibody cancer immunotherapy candidate, DT-7012.

Samsung Biologics Partners with LegoChem Biosciences on ADCs

February 12, 2024

Under the new partnership, Samsung Biologics will develop and manufacture an antibody for a LegoChem Biosciences ADC candidate.

Purolite and Repligen Launch New Affinity Resin

February 07, 2024

Purolite and Repligen have commercially launched a new CH1 affinity resin for the purification of specialized mAbs.